NeuroGeneces
PrivateLast Round
Seed Round
May 1, 2026
Total Funding Raised
$386,000
Company Overview
NeuroGeneces is a healthcare technology company that provides an AI-powered smart-health platform for early detection of changes in brain function, up to 20 years before cognitive symptoms emerge.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Health IoT, Medical Devices, Healthcare Analytics, Precision Medicine
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroGeneces Comps
Public and private peers based on sector, stage, and business model.
NeuroGeneces Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 1, 2026 | ||||
| Grant | Feb 12, 2025 | ||||
| Grant | Jan 24, 2023 | ||||
| Grant | Jun 1, 2022 | ||||
| Accelerator | Jun 7, 2021 |
NeuroGeneces Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Accelerator |
| New Mexico Economic Development Department | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2026
$425K raised in Seed Round.
NeuroGeneces Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroGeneces's valuation, stock price, and market status.
